Incidence rates for RA, gout, systemic lupus erythematosus, ankylosing spondylitis, scleroderma, psoriatic arthritis, and osteoarthritis within 1 year after the index date served as the primary outcome
As we move deeper into 2025, with increasing awareness around preventative health and biological optimization, ReadyRx offers a reliable, scientifically validated option for those committed to making lasting improvements in their physiological and aesthetic wellness
Concurrently, glucagon-like peptide-1 (GLP-1) receptor agonists like Ozepmic, Tirzepatide, and a litany of others, have emerged as effective treatments for obesity and type 2 diabetes
The deepest body of mechanistic work on GHK-Cu has come from Loren Pickart and collaborators, who have published extensively on its biology across more than four decades (Pickart et al., 2015) In preclinical research, GHK-Cu has been associated with effects on collagen and glycosaminoglycan synthesis in dermal fibroblast models, on hair-follicle morphology in rodent and ex-vivo skin studies, and on expression of genes involved in tissue remodeling
Yet only 12% of GLP-1 users receive supplement guidance from their healthcare provider
By doing so, you create a robust foundation for sustained energy and mood enhancement